Filters
Term Search
You can select from the dropdown list OR enter your own terms to refine the search.
Last Updated: 10/31/2025
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 1167 publications
Corrigendum to "Abemaciclib plus a nonsteroidal aromatase inhibitor as initial therapy for HR+, HER2- advanced breast cancer: final overall survival results of MONARCH 3": [Ann Oncol 2024; 35: 718-727].
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: October 15, 2025
Real-world treatment outcomes of abemaciclib in older patients with HR+, HER2- metastatic breast cancer in Japan.
Journal: Future oncology (London, England)
Published: September 15, 2025
A Phase 1 study of abemaciclib plus abiraterone in Japanese patients with metastatic castration-resistant prostate cancer.
Journal: Journal of chemotherapy (Florence, Italy)
Published: September 09, 2025
Overall Survival with Abemaciclib in Early Breast Cancer.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: September 05, 2025
Unveiling the biophysical basis of DYRK kinase family isoform selectivity mechanism of Abemaciclib using computational approaches.
Journal: SAR and QSAR in environmental research
Published: September 04, 2025
Patient-derived organoids reveal hypoxia-driven plasticity and therapeutic vulnerabilities in pheochromocytomas and paragangliomas.
Journal: bioRxiv : the preprint server for biology
Published: September 02, 2025
Pulmonary Side Effects Associated With Abemaciclib the Antibreast Cancer Drug in Female Mice.
Journal: Journal of applied toxicology : JAT
Published: September 02, 2025
The Incidence of Abemaciclib-induced Interstitial Lung Disease: A Single-center Retrospective Study in Japan.
Journal: The Kobe journal of medical sciences
Published: September 02, 2025
Matching-adjusted indirect comparison of ribociclib + nonsteroidal aromatase inhibitor versus abemaciclib + endocrine therapy in hormone receptor-positive/HER2-negative early breast cancer.
Journal: Journal of comparative effectiveness research
Published: August 29, 2025
Letter to Editor on Qureshi et al. Efficacy and Safety of Abemaciclib in Combination with Endocrine Therapy for HR+/HER2- Advanced or Metastatic Breast Cancer a Systematic Review and Meta-Analysis, Am J Clin Oncol, 2025, 48(1).
Journal: American journal of clinical oncology
Published: August 22, 2025
TRADE: A phase II trial to assess the tolerability of abemaciclib dose escalation in early-stage HR+/HER2- breast cancer.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: August 21, 2025
Cardiovascular safety of CDK4/6 inhibitors in advance breast cancer: Assessing risks of QTc prolongation and thrombosis.
Journal: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners
Published: August 20, 2025
Last Updated: 10/31/2025